TheRas, Inc.
AI assistant that auto-generates clinical notes and documentation from therapy sessions
- Sector
- Digital health
- Headquarters
- PALO ALTO, CA
- Latest Form D
- $200M, May 2024
- Total capital
- $200M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $200M
- 1 Form D · last May 2024
- 29 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 20 pending · first 2026
- Rank in peer group#28 of 197
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$200M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 197 peers
Line = medianDigital health · Software
- Granted patents#28 · top 14%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Eli WallaceExecutive OfficerNamed in SEC Form D filings
- Frank McCormickDirectorNamed in SEC Form D filings
- Idan ElmelechExecutive OfficerNamed in SEC Form D filings
- Michelle DoigDirectorNamed in SEC Form D filings
- Neil KumarDirectorNamed in SEC Form D filings
- Pedro BeltranExecutive OfficerNamed in SEC Form D filings
Show all 7 people
- Raymond KelleherDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 21- GrantedCompositions And Methods For Inhibition Of RasUSPTOUS 12,528,818
- PendingCompositions And Methods For Inhibition Of RasUSPTOApplication 18291432
- PendingCompositions And Methods For Use In The Treatment Of Cancer And Other IndicationsUSPTOApplication PCTUS2025049656
Show all 21 patent records
- Compositions And Methods For Inhibition Of RasJan 20, 2026 · US 12,528,818Granted
- Compositions And Methods For Inhibition Of RasSep 12, 2024 · Application 18291432Pending
- Compositions And Methods For Use In The Treatment Of Cancer And Other IndicationsApplication PCTUS2025049656Pending
- Compositions And Methods For Use In The Treatment Of Cancer And Other IndicationsApplication PCTUS2025049653Pending
- Compositions And Methods For Use In The Treatment Of Cancer And Other IndicationsApplication PCTUS2025049658Pending
- Compositions And Methods For Use In The Treatment Of Cancer And Other IndicationsApplication 63846745Pending
- Compositions And Methods For Inhibition Of RasApplication PCTUS2024057867Pending
- Compositions And Methods For Use In The Treatment Of Cancer And Other IndicationsApplication 63704467Pending
- Treatment Methods With KRASG12C InhibitionApplication 63704462Pending
- Compositions And Methods For Use In The Treatment Of Cancer And Other IndicationsApplication 63704458Pending
- Compositions And Methods For Use In The Treatment Of Cancer And Other IndicationsApplication 63704468Pending
- Fused Pyridines For The Treatment Of Cancer And Other IndicationsApplication PCTUS2024041288Pending
- Fused Pyridazines For The Treatment Of Cancer And Other IndicationsApplication PCTUS2024041276Pending
- Compositions And Methods For Inhibition Of RasApplication PCTUS2024012559Pending
- Compositions And Methods For Inhibition Of RasApplication PCTUS2023029520Pending
- Compositions And Methods For Inhibition Of RasApplication PCTUS2023022831Pending
- Compositions And Methods For Use In The Treatment Of Cancer And Other IndicationsApplication PCTUS2023012521Pending
- Compositions And Methods For Inhibition Of RasApplication PCTUS2023010176Pending
- Compositions And Methods For Inhibition Of RasApplication PCTUS2023029537Pending
- Compositions And Methods For Inhibition Of RasApplication PCTUS2023010172Pending
- Treatment Methods With KRASG12C InhibitionApplication PCTUS2025049648Pending
Related companies, and why
- BISCHOFF HOLDINGS INCSimilar federal contract value in Digital health · null in contracts
- Lyra Health, Inc.Similar federal contract value in Digital health · null in contracts
- EMTRUTH, INC.Similar federal contract value in Digital health · null in contracts
- Akili Interactive Labs, Inc.Similar federal contract value in Digital health · null in contracts
- Livongo Health, Inc.Similar federal contract value in Digital health · null in contracts
- Flywheel Exchange Inc.Similar federal contract value in Digital health · null in contracts
Regulatory activity · Digital health
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .